touchONCOLOGY brings you the latest data presented at ESMO 2023.
New on-demand learning that addresses key clinical questions on the use of radiopharmaceuticals in advanced prostate cancer.
Watch three CME accredited videos featuring data presented at European Society of Medical Oncology (ESMO) 2023.
touchoncologyime.org/psma-tar...
This activity is funded by an independent medical education grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.
Негізгі бет PSMA-targeted radiopharmaceuticals: An evolving approach to prostate cancer management
Пікірлер: 2